STIMIT
- Company typePrivate
- Founded2018
- HeadquartersNidau, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
STIMIT firmographics
Firmographics- Name
- STIMIT
- Legal name
- STIMIT AG
- Website
- https://stimit.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
STIMIT industry classification
Industry- Product category
- Critical Care Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers) (HLAHAGAK)
Keywords
Where STIMIT is headquartered
LocationHeadquarters
- HQ city
- Nidau
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
STIMIT business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
STIMIT product offering
Product offeringCore offering
STIMIT develops and manufactures the STIMIT Activator 1, a medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients. The device is intended for use in ICUs and other critical care settings to address muscle atrophy and respiratory dysfunction associated with prolonged mechanical ventilation. The Activator 1 received market approval in Canada.
Product overview
STIMIT is a Swiss medtech startup that developed a single core medical device product—the STIMIT Activator 1—which provides non-invasive magnetic field technology for diaphragm muscle stimulation in mechanically ventilated intensive care patients. The company has been acquired by Hamilton Medical as of February 2026.
Differentiator
Problem solved
Functional benefit
Products and services
- STIMIT Activator 1 A medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients, intended for use by hospitals, ICUs, and critical care teams to prevent diaphragm atrophy and support respiratory recovery. The device received market approval in Canada.
Companies that use STIMIT
Customer profileSegments1 record
Ideal customer profiles1 record
STIMIT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
STIMIT partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hamilton MedicalcoreSTIMIT was acquired by Hamilton Medical, a Swiss-based manufacturer of critical care ventilation solutions. The integration combines both companies' expertise in critical care technology to drive joint growth. STIMIT's competencies in non-invasive magnetic field technologies for diaphragm stimulation will be integrated into the Hamilton Group to advance their positions in the critical care technology market.
Recent moves5 records
Expansion highlights5 records
STIMIT competitors and assessment
Company assessmentDirect peers
- Lungpacer Medical: Lungpacer Medical develops diaphragm stimulation therapy for mechanically ventilated patients, directly addressing the same ICU use case as STIMIT's Activator 1. It is one of the closest functional competitors in respiratory muscle stimulation for ventilated patients.
- Synapse Biomedical: Synapse Biomedical manufactures the NeuRx Diaphragm Pacing System for stimulating the diaphragm in ventilator-dependent patients. While its core system is invasive, it competes in the same clinical problem space and is frequently referenced in the diaphragm stimulation market.
Emerging players
- Liberate Medical: Liberate Medical develops non-invasive neuromuscular electrical stimulation for ventilated patients to improve weaning outcomes. It overlaps with STIMIT's mission of non-invasive diaphragm/respiratory muscle stimulation in ICU settings.
- Respinova: Respinova is an emerging medtech company developing non-invasive pulmonary airway stimulation technologies for COPD and respiratory patients. While its primary focus is chronic obstructive disease, its stimulation-based approach to respiratory therapy is conceptually adjacent to STIMIT's work.
- Atrotech: Atrotech develops targeted nerve and muscle stimulation technologies with potential applications in respiratory and critical care. It represents an emerging adjacent stimulation player whose modality and clinical focus overlap with STIMIT's non-invasive diaphragm stimulation platform.
Broad incumbents
- Hamilton Medical: Hamilton Medical is a global manufacturer of critical care ventilators and is also STIMIT's parent company post-acquisition. It represents the incumbent ICU ventilation platform into which STIMIT's technology is being integrated.
- Getinge: Getinge is a major ICU ventilation and critical care equipment manufacturer with a broad portfolio including ventilators used in the same ICU environments as STIMIT's target customers.
- Dräger: Dräger is a leading global manufacturer of ICU ventilators and patient monitoring solutions, serving the same hospital ICU customers that STIMIT targets with its diaphragm stimulation therapy.
- Medtronic: Medtronic operates a significant critical care and respiratory therapies business (including ventilators acquired via Covidien and other respiratory interventions). Its scale and ICU relationships make it a strategic comparable for the critical care respiratory market STIMIT addresses.
- Philips: Philips is a global player in hospital respiratory care and ICU patient monitoring, serving the same ICU customer base as STIMIT. Its broad portfolio positions it as a potential integrator of complementary respiratory muscle stimulation technologies.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
STIMIT financial estimates
Financial estimateRevenue estimate
Valuation estimate
STIMIT leadership team
Management profileNumber of profiles
Profiles2 records
STIMIT funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
STIMIT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about STIMIT
What does STIMIT do?
STIMIT develops and manufactures the STIMIT Activator 1, a medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients. The device is intended for use in ICUs and other critical care settings to address muscle atrophy and respiratory dysfunction associated with prolonged mechanical ventilation. The Activator 1 received market approval in Canada.
Is STIMIT a public or private company?
STIMIT is a private company. It is classified as corporate owned and is currently acquired.
When was STIMIT founded?
STIMIT was founded in 2018. It employs 11 to 50 people.
Where is STIMIT based?
STIMIT is headquartered in Nidau, Switzerland, in the Europe region.
Who are STIMIT's main competitors?
Direct peers on record are Lungpacer Medical and Synapse Biomedical. Emerging players are Liberate Medical, Respinova and Atrotech. Broad incumbents are Hamilton Medical, Getinge, Dräger, Medtronic and Philips.
Does STIMIT have an API?
No public API is recorded for STIMIT.
What industry is STIMIT in?
STIMIT's product category is Critical Care Medical Devices. Its primary akta.pro industry code is HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers). Its NAICS code is 334510 and its SIC code is 3841.